Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 201.30
+7.20 (3.71%)
At close: Jan 22, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 90.35 billion as of January 23, 2026. Its market cap has increased by 85.93% in one year.
Market Cap
90.35B
Enterprise Value
95.32B
Revenue
16.58B
Ranking
n/a
PE Ratio
127.76
Stock Price
201.30
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 90.35B, an increase of 25,880.43%. That is a compound annual growth rate of 30.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 90.35B | -0.38% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |
| Granules India | 138.61B |
| Caplin Point Laboratories | 131.86B |
| Rubicon Research | 109.49B |
| Sanofi India | 93.40B |
| Procter & Gamble Health | 89.66B |
| CORONA Remedies | 85.05B |